Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.

Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ.

Biol Psychiatry. 2005 Sep 1;58(5):355-63.

PMID:
16139581
2.

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P.

Biol Psychiatry. 2005 Sep 1;58(5):364-73.

PMID:
16139582
3.

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG.

Biol Psychiatry. 2005 Sep 1;58(5):347-54.

PMID:
16139580
4.

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH.

Biol Psychiatry. 2002 Feb 15;51(4):280-7.

PMID:
11958778
5.

Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.

Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS.

J Clin Psychiatry. 2005 Sep;66(9):1097-104.

PMID:
16187765
6.

A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.

Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, Sureddi S, Allen JC.

J Clin Psychiatry. 2008 Feb;69(2):183-9.

PMID:
18211128
7.

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, Nahas Z, Haines S, Simpson RK Jr, Goodman R.

Biol Psychiatry. 2000 Feb 15;47(4):276-86.

PMID:
10686262
8.

Vagus nerve stimulation for depression: efficacy and safety in a European study.

Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, Van den Abbeele D, Stanga Z, Hasdemir M.

Psychol Med. 2008 May;38(5):651-61. doi: 10.1017/S0033291707001924. Epub 2008 Jan 4. Erratum in: Psychol Med. 2008 Jul;38(7):1067. Matthews, K [removed]; Christmas, D [removed].

PMID:
18177525
9.

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.

Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson RK Jr, Goodman RR.

Neuropsychopharmacology. 2001 Nov;25(5):713-28.

10.

Two-year outcome of vagus nerve stimulation in treatment-resistant depression.

Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, van den Abbeele D, Matthews K, Christmas D, Eljamel S, Heuser I.

J Clin Psychopharmacol. 2010 Jun;30(3):273-81. doi: 10.1097/JCP.0b013e3181db8831.

PMID:
20473062
11.
12.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
13.

Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.

Rush AJ, Siefert SE.

Exp Neurol. 2009 Sep;219(1):36-43. doi: 10.1016/j.expneurol.2009.04.015. Epub 2009 May 3. Review.

PMID:
19397908
14.

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M.

Health Technol Assess. 2007 Jul;11(24):1-54.

17.

Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.

Dunner DL, Rush AJ, Russell JM, Burke M, Woodard S, Wingard P, Allen J.

J Clin Psychiatry. 2006 May;67(5):688-95.

PMID:
16841617
18.

Cervical vagus nerve stimulation for treatment-resistant depression.

Carpenter LL, Friehs GM, Price LH.

Neurosurg Clin N Am. 2003 Apr;14(2):275-82. Review.

PMID:
12856494
19.

Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.

Feighner JP, Sverdlov L, Hlavka J, Nicolau G, Cartwright K, Freed JS.

Int Clin Psychopharmacol. 2008 Jan;23(1):29-35.

PMID:
18090505
20.

A controlled trial of daily left prefrontal cortex TMS for treating depression.

George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, Arana GW, Risch SC, Ballenger JC.

Biol Psychiatry. 2000 Nov 15;48(10):962-70.

PMID:
11082469

Supplemental Content

Support Center